Gene: TMEM245
Official Full Name: transmembrane protein 245provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01042 | TMEM245 Knockout cell line (HeLa) | Human | TMEM245 | 1:3~1:6 | Negative | Online Inquiry |
KO28988 | TMEM245 Knockout cell line (HCT 116) | Human | TMEM245 | 1:2~1:4 | Negative | Online Inquiry |
KO28989 | TMEM245 Knockout cell line (HEK293) | Human | TMEM245 | 1:3~1:6 | Negative | Online Inquiry |
KO28990 | TMEM245 Knockout cell line (A549) | Human | TMEM245 | 1:3~1:4 | Negative | Online Inquiry |
TMEM245 Gene Knockout Cell Lines are a sophisticated tool designed for researchers seeking to understand the biological roles and mechanisms associated with the TMEM245 gene. This product features genetically engineered cell lines where the TMEM245 gene has been precisely knocked out, allowing for the comprehensive study of its function in various physiological and pathological contexts. By eliminating the gene's expression, scientists can observe resultant phenotypic changes, offering insights into cellular processes, signaling pathways, and potential therapeutic targets.
The core functionality of these knockout cell lines lies in their utility for dissecting the TMEM245 gene's roles in critical cellular functions such as cell proliferation, differentiation, and apoptosis. Researchers can utilize various assays, including proliferation assays and gene expression analysis, to reveal the complex interactions and downstream effects that are influenced by TMEM245. This is particularly vital in exploring its potential involvement in diseases such as cancer or neurodegenerative disorders, where gene expression regulation is crucial.
The scientific importance of TMEM245 Gene Knockout Cell Lines extends to both basic and applied research. In laboratory settings, these models provide a controlled environment for investigating gene function, enabling advancements in gene editing technologies and paving the way for novel therapeutic interventions. Clinically, understanding the implications of TMEM245 may contribute significantly to developing targeted treatments that can modulate its activity.
Compared to traditional cell lines or temporary knockdown methods, TMEM245 Gene Knockout Cell Lines present several distinct advantages. They offer stable and reproducible alterations to gene expression, which enhances the reliability of experimental outcomes. Moreover, these cell lines can lead to more prolonged studies without the variability introduced by transient systems, allowing researchers to make more informed conclusions.
For researchers and clinicians, investing in TMEM245 Gene Knockout Cell Lines represents a strategic step toward unraveling complex biological questions with relevance to human health. They facilitate the generation of transformative knowledge that can drive innovation in therapeutic strategies and precision medicine.
Our company is dedicated to advancing genetic research and therapeutic development, offering a range of high-quality biological products, including these specialized knockout cell lines. With expertise in molecular biology and an unwavering commitment to scientific excellence, we equip researchers with the tools necessary to drive breakthroughs across various fields of study.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.